Related Experiment Video
Updated: Jun 3, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
Multipotent adult progenitor cells.
Abhishek Sohni1, Catherine M Verfaillie
1Interdepartementaal Stamcelinstituut, Katholieke Universiteit Leuven, O&N1, bus 804, Herestraat 49, 3000 Leuven, Belgium. Abhishek.Sohni@med.kuleuven.be
Multipotent adult progenitor cells (MAPC) show significant potential due to epigenetic modifications that enhance their potency. These stem cells offer promising clinical applications in regenerative medicine.
Area of Science:
- Stem cell biology
- Epigenetics
- Regenerative medicine
Background:
- Adult-derived adherent stem cells are crucial for regenerative therapies.
- Multipotent adult progenitor cells (MAPC) were first isolated in 2002.
- Understanding stem cell potency is key to clinical translation.
Purpose of the Study:
- To discuss the potency and characteristics of MAPC.
- To explore novel epigenetic modifications that increase cellular potency.
- To review the clinical applications of MAPC.
Main Methods:
- Review of existing literature on MAPC.
- Analysis of epigenetic mechanisms influencing stem cell potency.
- Evaluation of preclinical and clinical data.
Main Results:
- MAPC exhibit remarkable multipotency and self-renewal capabilities.
- Epigenetic reprogramming significantly enhances MAPC potency.
- MAPC demonstrate potential in various therapeutic models.
Conclusions:
- MAPC are a promising stem cell source for regenerative medicine.
- Epigenetic strategies can optimize MAPC for clinical use.
- Further research is warranted to fully realize MAPC therapeutic potential.
More Related Videos
Related Concept Videos
Source And Potency Of Stem Cells
Multipotency of Hematopoietic Stem Cells
Production of Formed Elements
Most HSCs commit to...
Differentiation of Common Myeloid Progenitor Cells
Lineage Commitment
Adult Stem Cells

